

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.82149763 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.26728672 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.26728672 |
| 4 | negative regulation of cell killing (GO:0031342) | 6.08294634 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.08294634 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.83404168 |
| 7 | negative T cell selection (GO:0043383) | 5.69440582 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.55263782 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.48035980 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.17336210 |
| 11 | positive thymic T cell selection (GO:0045059) | 5.12036612 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 5.11202930 |
| 13 | interferon-gamma production (GO:0032609) | 4.92187163 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90598613 |
| 15 | thymic T cell selection (GO:0045061) | 4.73269583 |
| 16 | positive T cell selection (GO:0043368) | 4.70986191 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.64784629 |
| 18 | T cell migration (GO:0072678) | 4.51927886 |
| 19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.44522246 |
| 20 | * response to interleukin-15 (GO:0070672) | 4.43253094 |
| 21 | T cell selection (GO:0045058) | 4.43062430 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.18380502 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.09924151 |
| 24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.05000783 |
| 25 | leukocyte aggregation (GO:0070486) | 3.86378557 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78676010 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78676010 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.78676010 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78676010 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.78676010 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78676010 |
| 32 | T cell costimulation (GO:0031295) | 3.71436871 |
| 33 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.69388720 |
| 34 | lymphocyte costimulation (GO:0031294) | 3.65461153 |
| 35 | T cell receptor signaling pathway (GO:0050852) | 3.60143101 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.54470352 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.53272210 |
| 38 | activated T cell proliferation (GO:0050798) | 3.53184201 |
| 39 | * cellular response to interleukin-15 (GO:0071350) | 3.51213091 |
| 40 | leukocyte cell-cell adhesion (GO:0007159) | 3.47748308 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.46745118 |
| 42 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.46745118 |
| 43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.46568658 |
| 44 | positive regulation of isotype switching (GO:0045830) | 3.45593892 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43301659 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.37861278 |
| 47 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.37309362 |
| 48 | detection of other organism (GO:0098543) | 3.37237302 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.36968705 |
| 50 | positive regulation of tolerance induction (GO:0002645) | 3.31937728 |
| 51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31056570 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.30007491 |
| 53 | tolerance induction (GO:0002507) | 3.25970394 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.25945278 |
| 55 | detection of molecule of bacterial origin (GO:0032490) | 3.23914553 |
| 56 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.22541705 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.22253187 |
| 58 | leukocyte tethering or rolling (GO:0050901) | 3.20600368 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20465686 |
| 60 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.19663814 |
| 61 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.19663814 |
| 62 | positive regulation of interleukin-2 production (GO:0032743) | 3.17516542 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.16588066 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.15610857 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.15536807 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.14763192 |
| 67 | detection of bacterium (GO:0016045) | 3.11586581 |
| 68 | detection of external biotic stimulus (GO:0098581) | 3.08561398 |
| 69 | natural killer cell differentiation (GO:0001779) | 3.04960739 |
| 70 | natural killer cell activation (GO:0030101) | 3.03272525 |
| 71 | positive regulation of DNA recombination (GO:0045911) | 3.02799087 |
| 72 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.99440477 |
| 73 | response to muramyl dipeptide (GO:0032495) | 2.96969481 |
| 74 | heterotypic cell-cell adhesion (GO:0034113) | 2.95674212 |
| 75 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93982601 |
| 76 | * regulation of response to interferon-gamma (GO:0060330) | 2.93824929 |
| 77 | * response to type I interferon (GO:0034340) | 2.93662628 |
| 78 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.93575914 |
| 79 | positive regulation of B cell mediated immunity (GO:0002714) | 2.93575914 |
| 80 | response to peptidoglycan (GO:0032494) | 2.93459914 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92231071 |
| 82 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.91385552 |
| 83 | regulation of isotype switching (GO:0045191) | 2.91089481 |
| 84 | growth hormone receptor signaling pathway (GO:0060396) | 2.90273133 |
| 85 | * regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.85955482 |
| 86 | mast cell activation (GO:0045576) | 2.85721402 |
| 87 | lymphocyte migration (GO:0072676) | 2.84421845 |
| 88 | * type I interferon signaling pathway (GO:0060337) | 2.84387723 |
| 89 | * cellular response to type I interferon (GO:0071357) | 2.84387723 |
| 90 | germinal center formation (GO:0002467) | 2.84010408 |
| 91 | positive regulation of humoral immune response (GO:0002922) | 2.80749011 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.79173621 |
| 93 | JAK-STAT cascade (GO:0007259) | 2.78731120 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78697334 |
| 95 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.78508746 |
| 96 | T cell proliferation (GO:0042098) | 2.78316472 |
| 97 | cellular extravasation (GO:0045123) | 2.78298621 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 2.78129391 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77922594 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76788352 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76788352 |
| 102 | regulation of cell killing (GO:0031341) | 2.76356096 |
| 103 | positive regulation of lamellipodium assembly (GO:0010592) | 2.75597015 |
| 104 | macrophage activation (GO:0042116) | 2.74610492 |
| 105 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73434761 |
| 106 | cellular defense response (GO:0006968) | 2.72494938 |
| 107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71913798 |
| 108 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71810148 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71446795 |
| 110 | response to host (GO:0075136) | 2.71446795 |
| 111 | response to host defenses (GO:0052200) | 2.71446795 |
| 112 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.70449931 |
| 113 | alpha-beta T cell activation (GO:0046631) | 2.70267384 |
| 114 | regulation of necroptotic process (GO:0060544) | 2.69148136 |
| 115 | cellular response to ethanol (GO:0071361) | 2.69077334 |
| 116 | interferon-gamma secretion (GO:0072643) | 2.67810467 |
| 117 | megakaryocyte development (GO:0035855) | 2.67296779 |
| 118 | neutrophil activation (GO:0042119) | 2.66978383 |
| 119 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.66973237 |
| 120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66691309 |
| 121 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65332069 |
| 122 | response to host immune response (GO:0052572) | 2.65332069 |
| 123 | positive regulation of immunoglobulin production (GO:0002639) | 2.65142691 |
| 124 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64546223 |
| 125 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.64105160 |
| 126 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.63109187 |
| 127 | response to laminar fluid shear stress (GO:0034616) | 2.62522428 |
| 128 | regulation of B cell mediated immunity (GO:0002712) | 2.61861738 |
| 129 | angiogenesis involved in wound healing (GO:0060055) | 2.61766927 |
| 130 | detection of biotic stimulus (GO:0009595) | 2.61519130 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 2.59965314 |
| 132 | microglial cell activation (GO:0001774) | 2.59643003 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59641809 |
| 134 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58557892 |
| 135 | T cell homeostasis (GO:0043029) | 2.57853786 |
| 136 | positive regulation of histone deacetylation (GO:0031065) | 2.57535265 |
| 137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.57409652 |
| 138 | hepatocyte apoptotic process (GO:0097284) | 2.55911870 |
| 139 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.55071367 |
| 140 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.54400965 |
| 141 | immunoglobulin mediated immune response (GO:0016064) | 2.52312202 |
| 142 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51782639 |
| 143 | granulocyte activation (GO:0036230) | 2.50728895 |
| 144 | negative regulation of adaptive immune response (GO:0002820) | 2.49921329 |
| 145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47022912 |
| 146 | negative regulation of type 2 immune response (GO:0002829) | 2.46054923 |
| 147 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.45735445 |
| 148 | defense response to protozoan (GO:0042832) | 2.45622810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.28435122 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.91626869 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.92910407 |
| 4 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.57175090 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.52684982 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33846708 |
| 7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.33803881 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25695151 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25035361 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18045609 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.16765208 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.87309994 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87026962 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.76500740 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72322556 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.60897268 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58627099 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57406165 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55982440 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.46634238 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35172036 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32133697 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31713348 |
| 24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.28654626 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22999817 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17056280 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.15522898 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05346956 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03434033 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01788005 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89439278 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88994520 |
| 33 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.87164851 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84849965 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79622897 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77137325 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76790124 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74187465 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73927664 |
| 40 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.73407166 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73023315 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71843760 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70460221 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64169339 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57112284 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54571589 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53891297 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53435197 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45413300 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39321403 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39123967 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39011978 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.37738446 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35450517 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.33230474 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31216725 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29799517 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26878389 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23980516 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23855500 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23100675 |
| 62 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19949399 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19445723 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.19073940 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18023943 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17374353 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17315547 |
| 68 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14504753 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14056940 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10655877 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08192955 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04675554 |
| 73 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02508792 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99326418 |
| 75 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97020643 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95484959 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94764183 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92618396 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91941509 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91365723 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89440536 |
| 82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89440536 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88654567 |
| 84 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88036035 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87759944 |
| 86 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87225528 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86630364 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86157768 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86068578 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85750556 |
| 91 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85277312 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82089046 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82089046 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81856959 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81590961 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81295126 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81249623 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.80587114 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80557102 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79842289 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79329757 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75002271 |
| 103 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74374505 |
| 104 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72666229 |
| 105 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72366597 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71673198 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70639121 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70600094 |
| 109 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69576576 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67858889 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66949272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.61884843 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.59016427 |
| 3 | MP0005671_abnormal_response_to | 3.56677149 |
| 4 | MP0000685_abnormal_immune_system | 3.34080152 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.01012501 |
| 6 | MP0001800_abnormal_humoral_immune | 2.86416988 |
| 7 | MP0005387_immune_system_phenotype | 2.79807397 |
| 8 | MP0001790_abnormal_immune_system | 2.79807397 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.68534438 |
| 10 | MP0003724_increased_susceptibility_to | 2.61441980 |
| 11 | MP0002723_abnormal_immune_serum | 2.46293022 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.45430988 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.45207240 |
| 14 | MP0003436_decreased_susceptibility_to | 2.44818758 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.44554254 |
| 16 | MP0009785_altered_susceptibility_to | 2.44441418 |
| 17 | MP0001819_abnormal_immune_cell | 2.42118376 |
| 18 | MP0006054_spinal_hemorrhage | 2.41061656 |
| 19 | MP0001873_stomach_inflammation | 2.25942964 |
| 20 | MP0005025_abnormal_response_to | 2.24722247 |
| 21 | * MP0002398_abnormal_bone_marrow | 2.21245802 |
| 22 | MP0003303_peritoneal_inflammation | 2.17083868 |
| 23 | MP0005451_abnormal_body_composition | 2.16154613 |
| 24 | MP0004947_skin_inflammation | 2.14443527 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.14256813 |
| 26 | MP0006082_CNS_inflammation | 2.11845431 |
| 27 | MP0002419_abnormal_innate_immunity | 2.05659224 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.04532755 |
| 29 | MP0004510_myositis | 2.03143319 |
| 30 | MP0002006_tumorigenesis | 1.99481660 |
| 31 | * MP0000716_abnormal_immune_system | 1.96529202 |
| 32 | MP0002405_respiratory_system_inflammati | 1.95597214 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.90872386 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.85045587 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.80085525 |
| 36 | MP0008260_abnormal_autophagy | 1.75939525 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.73693384 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.73516194 |
| 39 | * MP0002722_abnormal_immune_system | 1.72787802 |
| 40 | MP0002933_joint_inflammation | 1.72587654 |
| 41 | * MP0000703_abnormal_thymus_morphology | 1.69064593 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.68350839 |
| 43 | * MP0002429_abnormal_blood_cell | 1.57499737 |
| 44 | MP0003866_abnormal_defecation | 1.53983864 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.52408630 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.49898905 |
| 47 | MP0003045_fibrosis | 1.45150412 |
| 48 | MP0001853_heart_inflammation | 1.44034711 |
| 49 | MP0001851_eye_inflammation | 1.41525660 |
| 50 | MP0003279_aneurysm | 1.37638791 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.37447996 |
| 52 | MP0000858_altered_metastatic_potential | 1.36601562 |
| 53 | MP0009278_abnormal_bone_marrow | 1.32887361 |
| 54 | MP0003448_altered_tumor_morphology | 1.31535822 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.30857020 |
| 56 | MP0004883_abnormal_blood_vessel | 1.30118657 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.30059570 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.30059570 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.29272770 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.28395320 |
| 61 | MP0005164_abnormal_response_to | 1.21675201 |
| 62 | MP0005310_abnormal_salivary_gland | 1.19584226 |
| 63 | MP0008469_abnormal_protein_level | 1.19362514 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.14603903 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.12517308 |
| 66 | MP0008004_abnormal_stomach_pH | 1.11331486 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.11159685 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.09303888 |
| 69 | MP0003091_abnormal_cell_migration | 1.07902580 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 1.06896683 |
| 71 | MP0005023_abnormal_wound_healing | 1.06866032 |
| 72 | MP0000343_altered_response_to | 1.05313361 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.04632821 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.04523306 |
| 75 | MP0004381_abnormal_hair_follicle | 1.03757095 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.02949207 |
| 77 | MP0003690_abnormal_glial_cell | 0.99662147 |
| 78 | MP0003828_pulmonary_edema | 0.98098514 |
| 79 | MP0002009_preneoplasia | 0.97881702 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.96886210 |
| 81 | MP0001958_emphysema | 0.92483654 |
| 82 | MP0009840_abnormal_foam_cell | 0.88611715 |
| 83 | MP0000604_amyloidosis | 0.88185613 |
| 84 | MP0009764_decreased_sensitivity_to | 0.87544058 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.86694219 |
| 86 | MP0000249_abnormal_blood_vessel | 0.83539484 |
| 87 | MP0005409_darkened_coat_color | 0.82815406 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.82723527 |
| 89 | MP0005166_decreased_susceptibility_to | 0.82397101 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.81537922 |
| 91 | MP0004484_altered_response_of | 0.80357881 |
| 92 | MP0003795_abnormal_bone_structure | 0.79034357 |
| 93 | MP0001243_abnormal_dermal_layer | 0.78647618 |
| 94 | MP0002928_abnormal_bile_duct | 0.78306579 |
| 95 | MP0004130_abnormal_muscle_cell | 0.77786791 |
| 96 | MP0002132_abnormal_respiratory_system | 0.75238221 |
| 97 | MP0001915_intracranial_hemorrhage | 0.74375691 |
| 98 | MP0005390_skeleton_phenotype | 0.74313887 |
| 99 | MP0005275_abnormal_skin_tensile | 0.73152507 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.72880756 |
| 101 | MP0009763_increased_sensitivity_to | 0.71065461 |
| 102 | MP0000569_abnormal_digit_pigmentation | 0.70480557 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.69690339 |
| 104 | MP0002254_reproductive_system_inflammat | 0.69688925 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.69442964 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.68659789 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.66126372 |
| 108 | MP0000609_abnormal_liver_physiology | 0.64535055 |
| 109 | MP0002060_abnormal_skin_morphology | 0.63834681 |
| 110 | MP0001191_abnormal_skin_condition | 0.62013598 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.61377951 |
| 112 | MP0003075_altered_response_to | 0.59999272 |
| 113 | MP0002168_other_aberrant_phenotype | 0.59840699 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.57829791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.69254080 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.56432417 |
| 3 | Myositis (HP:0100614) | 4.08856194 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.06894025 |
| 5 | Recurrent bronchitis (HP:0002837) | 3.71569521 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67646668 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.65156116 |
| 8 | Recurrent viral infections (HP:0004429) | 3.63001714 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.56340433 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.47300837 |
| 11 | Chronic otitis media (HP:0000389) | 3.39683142 |
| 12 | Abnormality of T cells (HP:0002843) | 3.37104121 |
| 13 | Spontaneous hematomas (HP:0007420) | 3.29052137 |
| 14 | IgM deficiency (HP:0002850) | 3.25737905 |
| 15 | Orchitis (HP:0100796) | 3.23216408 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.22846219 |
| 17 | Nasal polyposis (HP:0100582) | 3.21830464 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 3.14369164 |
| 19 | Aortic aneurysm (HP:0004942) | 3.07287055 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.02667137 |
| 21 | Optic neuritis (HP:0100653) | 3.02667137 |
| 22 | Arterial thrombosis (HP:0004420) | 3.00983128 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95972321 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95972321 |
| 25 | Increased IgE level (HP:0003212) | 2.91617803 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 2.91523625 |
| 27 | Pustule (HP:0200039) | 2.84996181 |
| 28 | Spondylolisthesis (HP:0003302) | 2.84791153 |
| 29 | Agammaglobulinemia (HP:0004432) | 2.80917537 |
| 30 | Hematochezia (HP:0002573) | 2.78103552 |
| 31 | Vasculitis (HP:0002633) | 2.77346626 |
| 32 | Meningitis (HP:0001287) | 2.75528930 |
| 33 | Cellulitis (HP:0100658) | 2.74490945 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.73424073 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 2.72976185 |
| 36 | Stomatitis (HP:0010280) | 2.71870629 |
| 37 | Spinal cord lesions (HP:0100561) | 2.66729109 |
| 38 | Syringomyelia (HP:0003396) | 2.66729109 |
| 39 | Peritonitis (HP:0002586) | 2.64261854 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.62900294 |
| 41 | Recurrent skin infections (HP:0001581) | 2.60968087 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60942087 |
| 43 | Verrucae (HP:0200043) | 2.58510380 |
| 44 | Papilloma (HP:0012740) | 2.58510380 |
| 45 | Subacute progressive viral hepatitis (HP:0006572) | 2.56501649 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.55379872 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.54622288 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.54609205 |
| 49 | IgG deficiency (HP:0004315) | 2.49825308 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.49128210 |
| 51 | Absent frontal sinuses (HP:0002688) | 2.47792476 |
| 52 | Myocardial infarction (HP:0001658) | 2.47741651 |
| 53 | Colitis (HP:0002583) | 2.44540530 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.42752387 |
| 55 | Lymphopenia (HP:0001888) | 2.39979530 |
| 56 | Leukocytosis (HP:0001974) | 2.39485400 |
| 57 | Hemoptysis (HP:0002105) | 2.39184113 |
| 58 | Eosinophilia (HP:0001880) | 2.37044043 |
| 59 | Aortic dissection (HP:0002647) | 2.36475148 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.35913783 |
| 61 | Emphysema (HP:0002097) | 2.35561746 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35498314 |
| 63 | Obstructive lung disease (HP:0006536) | 2.35498314 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.35349517 |
| 65 | Joint swelling (HP:0001386) | 2.35186783 |
| 66 | Epistaxis (HP:0000421) | 2.32476622 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.30189675 |
| 68 | Chronic diarrhea (HP:0002028) | 2.30175787 |
| 69 | Thyroiditis (HP:0100646) | 2.28620117 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.27598177 |
| 71 | Dilatation of the ascending aorta (HP:0005111) | 2.26581392 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26507676 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.25957345 |
| 74 | Abnormal platelet volume (HP:0011876) | 2.25057619 |
| 75 | Pulmonary embolism (HP:0002204) | 2.23059346 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22998258 |
| 77 | Periodontitis (HP:0000704) | 2.22869185 |
| 78 | Thrombocytosis (HP:0001894) | 2.22082418 |
| 79 | Encephalitis (HP:0002383) | 2.20553175 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.19537524 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.17894900 |
| 82 | Chest pain (HP:0100749) | 2.15782862 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.15169088 |
| 84 | Severe combined immunodeficiency (HP:0004430) | 2.13599013 |
| 85 | Striae distensae (HP:0001065) | 2.11410262 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.11288555 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.10179607 |
| 88 | Arterial tortuosity (HP:0005116) | 2.09145235 |
| 89 | Polycythemia (HP:0001901) | 2.08583039 |
| 90 | Viral hepatitis (HP:0006562) | 2.08576056 |
| 91 | Gingival bleeding (HP:0000225) | 2.08098020 |
| 92 | Protrusio acetabuli (HP:0003179) | 2.07393701 |
| 93 | Combined immunodeficiency (HP:0005387) | 2.07158594 |
| 94 | Fatigue (HP:0012378) | 2.07069370 |
| 95 | IgA deficiency (HP:0002720) | 2.01811510 |
| 96 | Vascular tortuosity (HP:0004948) | 2.00870248 |
| 97 | Abnormality of B cell number (HP:0010975) | 2.00566643 |
| 98 | B lymphocytopenia (HP:0010976) | 2.00566643 |
| 99 | Gingivitis (HP:0000230) | 1.99458510 |
| 100 | Abnormality of macrophages (HP:0004311) | 1.99317341 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97534271 |
| 102 | Impaired platelet aggregation (HP:0003540) | 1.97026486 |
| 103 | Abnormal platelet function (HP:0011869) | 1.97026486 |
| 104 | Increased mean platelet volume (HP:0011877) | 1.96684986 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 1.96596125 |
| 106 | Osteomyelitis (HP:0002754) | 1.96590770 |
| 107 | Persistence of primary teeth (HP:0006335) | 1.95591504 |
| 108 | Granulocytopenia (HP:0001913) | 1.94641845 |
| 109 | Increased density of long bones (HP:0006392) | 1.94343016 |
| 110 | Urticaria (HP:0001025) | 1.94235669 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 1.93610779 |
| 112 | Facial diplegia (HP:0001349) | 1.92176847 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91790456 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91790456 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91790456 |
| 116 | Chronic sinusitis (HP:0011109) | 1.90027906 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 1.89574353 |
| 118 | Amyloidosis (HP:0011034) | 1.88165668 |
| 119 | Glomerulopathy (HP:0100820) | 1.87760632 |
| 120 | Mucopolysacchariduria (HP:0008155) | 1.86999244 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86999244 |
| 122 | Increased CSF protein (HP:0002922) | 1.86428605 |
| 123 | Gangrene (HP:0100758) | 1.85617576 |
| 124 | Mitral stenosis (HP:0001718) | 1.85172451 |
| 125 | Vertebral compression fractures (HP:0002953) | 1.83959596 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 1.79949307 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78320097 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78320097 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78320097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.50159389 |
| 2 | TXK | 3.66090925 |
| 3 | PRPF4B | 2.79087901 |
| 4 | MAP3K14 | 2.65614389 |
| 5 | TYK2 | 2.58032025 |
| 6 | FGFR4 | 2.56729477 |
| 7 | JAK1 | 2.52774049 |
| 8 | ITK | 2.52583564 |
| 9 | * JAK3 | 2.45837272 |
| 10 | FGFR3 | 2.26959679 |
| 11 | ZAP70 | 2.26545519 |
| 12 | STK10 | 2.13554472 |
| 13 | IKBKE | 2.10217599 |
| 14 | TGFBR2 | 2.03533263 |
| 15 | TRIB3 | 2.00605267 |
| 16 | GRK6 | 1.91908237 |
| 17 | TBK1 | 1.85503200 |
| 18 | KDR | 1.83061538 |
| 19 | MAP3K13 | 1.72172434 |
| 20 | NLK | 1.72146140 |
| 21 | PIK3CG | 1.71001211 |
| 22 | EPHA3 | 1.70657358 |
| 23 | PKN2 | 1.67440434 |
| 24 | RIPK4 | 1.58028786 |
| 25 | EPHB1 | 1.57680573 |
| 26 | ERN1 | 1.56855144 |
| 27 | BMPR2 | 1.50140691 |
| 28 | SYK | 1.50108597 |
| 29 | BTK | 1.48775944 |
| 30 | EEF2K | 1.47000709 |
| 31 | TEC | 1.42708934 |
| 32 | KIT | 1.37822450 |
| 33 | PRKCH | 1.37046509 |
| 34 | * LCK | 1.36346317 |
| 35 | SIK2 | 1.35993186 |
| 36 | MAP3K10 | 1.35681363 |
| 37 | CSK | 1.35170718 |
| 38 | SIK3 | 1.32996933 |
| 39 | HCK | 1.27060702 |
| 40 | BLK | 1.24529402 |
| 41 | TTN | 1.24194954 |
| 42 | NEK9 | 1.24177614 |
| 43 | JAK2 | 1.22186950 |
| 44 | MARK3 | 1.18479872 |
| 45 | LRRK2 | 1.18259544 |
| 46 | MAP2K3 | 1.13193158 |
| 47 | KSR2 | 1.12559104 |
| 48 | IKBKB | 1.11888792 |
| 49 | IRAK4 | 1.11678182 |
| 50 | CAMKK2 | 1.05018692 |
| 51 | TAOK3 | 1.03741568 |
| 52 | RIPK1 | 0.97955049 |
| 53 | CHUK | 0.96634893 |
| 54 | FGR | 0.95294386 |
| 55 | IRAK3 | 0.92131191 |
| 56 | MAPK7 | 0.90714163 |
| 57 | MAP3K12 | 0.88776613 |
| 58 | PRKCQ | 0.87991560 |
| 59 | TGFBR1 | 0.87731852 |
| 60 | MARK2 | 0.86665653 |
| 61 | PDGFRB | 0.84558109 |
| 62 | TRPM7 | 0.83774988 |
| 63 | MAP3K6 | 0.83305026 |
| 64 | RET | 0.82312228 |
| 65 | CDC42BPA | 0.82056013 |
| 66 | PIM1 | 0.82053727 |
| 67 | PTK6 | 0.81154287 |
| 68 | SIK1 | 0.80259509 |
| 69 | MAP3K7 | 0.80155187 |
| 70 | CSF1R | 0.79412177 |
| 71 | FES | 0.77215195 |
| 72 | DMPK | 0.75219450 |
| 73 | STK24 | 0.72857052 |
| 74 | PDK1 | 0.71591074 |
| 75 | MAP3K11 | 0.71403328 |
| 76 | STK38 | 0.70649730 |
| 77 | PDGFRA | 0.69872189 |
| 78 | FLT3 | 0.69596724 |
| 79 | HIPK2 | 0.69254761 |
| 80 | YES1 | 0.69197990 |
| 81 | RPS6KA4 | 0.68512612 |
| 82 | PDPK1 | 0.66592084 |
| 83 | PTK2B | 0.64937744 |
| 84 | MAP3K3 | 0.63362714 |
| 85 | SGK3 | 0.63167740 |
| 86 | CDK9 | 0.61911219 |
| 87 | TIE1 | 0.61811701 |
| 88 | LYN | 0.60414895 |
| 89 | CAMKK1 | 0.56256366 |
| 90 | CLK1 | 0.55673228 |
| 91 | NEK6 | 0.55135372 |
| 92 | MAPK12 | 0.55120546 |
| 93 | TNK2 | 0.54598036 |
| 94 | TAOK1 | 0.53343973 |
| 95 | TAOK2 | 0.52896272 |
| 96 | MAP3K1 | 0.52522631 |
| 97 | CDK12 | 0.50050878 |
| 98 | SCYL2 | 0.48947074 |
| 99 | MOS | 0.46165776 |
| 100 | BRD4 | 0.44713016 |
| 101 | CDK4 | 0.44389045 |
| 102 | WNK1 | 0.43863589 |
| 103 | IRAK2 | 0.42262224 |
| 104 | IGF1R | 0.42245507 |
| 105 | MAP3K5 | 0.41762790 |
| 106 | GRK7 | 0.40387400 |
| 107 | IRAK1 | 0.40304100 |
| 108 | MST4 | 0.39362566 |
| 109 | ALK | 0.38927323 |
| 110 | FGFR2 | 0.37233179 |
| 111 | CDK6 | 0.35984238 |
| 112 | MAP3K2 | 0.35649167 |
| 113 | MELK | 0.35438402 |
| 114 | MAPK4 | 0.35353053 |
| 115 | RPS6KA2 | 0.34682752 |
| 116 | FRK | 0.33876096 |
| 117 | SGK2 | 0.33701622 |
| 118 | MAPK3 | 0.33201456 |
| 119 | FYN | 0.33041099 |
| 120 | MAPK11 | 0.32276951 |
| 121 | MAPKAPK2 | 0.32261975 |
| 122 | EGFR | 0.31543461 |
| 123 | PRKD2 | 0.30980941 |
| 124 | INSR | 0.30573205 |
| 125 | PTK2 | 0.28953789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.36668312 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.58746955 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.54564001 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50594929 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.47519582 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20849401 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19172033 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17228401 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16251049 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11753083 |
| 11 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.07035437 |
| 12 | * Measles_Homo sapiens_hsa05162 | 2.02382107 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69298913 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.64816394 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63307978 |
| 16 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55697313 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55428364 |
| 18 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.52089087 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.49576241 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48577507 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48539215 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48201971 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44555828 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43965314 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43876778 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39638486 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.39523712 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34796654 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32856235 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31795372 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29524585 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28552969 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.25535737 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24355144 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22217458 |
| 36 | * Influenza A_Homo sapiens_hsa05164 | 1.21421798 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17394888 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16905183 |
| 39 | * Hepatitis B_Homo sapiens_hsa05161 | 1.16505477 |
| 40 | * Tuberculosis_Homo sapiens_hsa05152 | 1.15169897 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.14476682 |
| 42 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.14245659 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.08222358 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05897776 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.02678208 |
| 46 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.00647643 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99473797 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98655747 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.92756441 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.92718984 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92708078 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92274672 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90642756 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90258803 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86717687 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85678037 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.84423336 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.83726507 |
| 59 | * Hepatitis C_Homo sapiens_hsa05160 | 0.81970156 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.78996510 |
| 61 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.77404645 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76544305 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76179746 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75814563 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74985222 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74417864 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73386997 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72643541 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71675611 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71615911 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70909997 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70370247 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69174892 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69146705 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.67788788 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67020030 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66644547 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65787784 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63395460 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63310106 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63089052 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.62897257 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62495111 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62160615 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61137039 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60413254 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.59242833 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59124161 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59025199 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58626241 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57507509 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57459194 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.56344443 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54336504 |
| 95 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53903759 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52232497 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50921527 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50733526 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50502429 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50351547 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48583084 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48501320 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48429051 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48261020 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48130190 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.47254518 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44972717 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43923176 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43853913 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.43426038 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41780656 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41768277 |

